Hillier, C. and Bunton, D.C.
Could human tissues play a key role in drug development? ATLA 2009; 37, Suppl 1, 5-10
Bunton D.C., Rankin L. and Corbett A.D.
New frontiers in opioid research. European Biopharmaceutical Review. January 2009; pages 46-49.
Keen, J. Hillier, C., McGorum, B., Bunton, D. & Nally, J.E.
Evaluation of equine laminar vein function: harvesting, dissection and the use of functional methods to distinguish between veins and arteries. J Pharmacol Toxicol Methods. 2008; 57, 92-9.
Bunton D. C, Petrie M.C, Hillier C, Johnston F, McMurray J.J.V.
The clinical relevance of adrenomedullin: a promising profile? Pharm Ther 2004; 103: 179-201.
Bunton, D.C., MacDonald, A. & Shaw, A. M.
Effect of inhibition of endogenous nitric oxide on responses to 5-Hydroytryptamine and U46619 in bovine pulmonary conventional and supernumerary arteries. Clin Sci 2000; 98: 81-89.
Nally, J.E., Bunton, D.C., Martin, D. & Thomson, N.C.
The role of cyclooxygenase and 5-lipoxygenase metabolites in bovine bronchi. Pulm Pharmacol 1996; 9: 211-217.
Shaw, A.M., Bunton, D.C., Brown, T., Irvine, J., MacDonald, A.
Regulation of sensitivity to 5-hydroxytryptamine in pulmonary supernumerary but not conventional arteries by a 5-HT1D-like receptor. Eur J Pharmacol. 2000; 408: 69-82.
Shaw, A. M., Bunton, D.C. et al.
V-shaped cushion at the origin of bovine pulmonary supernumerary arteries: structure and putative function. J Appl Physiol 1999; 87: 2348-2356.
Tracey, A., Bunton, D., Irvine, J., MacDonald, A. & Shaw, A.M.
Relaxation to bradykinin in bovine pulmonary supernumerary arteries can be mediated by both a nitric oxide-dependent and –independent mechanism. Br J Pharmacol 2002; 137: 538-544.
Test document
Click to download